Brand in Focus | Vanguard Diagnostics


Reagent leader, Vanguard Diagnostics is appending accuracy and accessibility to the domain with high quality and affordable diagnostics tools. 

Vanguard Diagnostics is a development and manufacturing company in the in-vitro Diagnostics space and was founded in February, 2015 at New Delhi. Its flagship product line is Hematology. During the pandemic, the company decided to channelize its energy towards meeting the need of the hour and came up with solutions for Covid-19.

The company developed the VDx Viral Transport Kit which is a 100% ‘Made in India’ product.

It is a specially designed product, for the safe collection and transport of Covid -19 specimens, to the laboratory, for testing by the RT PCR method. The company was able to up-scale this product from a batch size of one Litre to 10 Litres batches within one week and increase the production capacity by 400-fold in 4 weeks.

The company was awarded by FICCI in the year 2020 for ‘Excellence in Scaling up Manufacturing for Meeting the Covid-19 demand. 

Vanguard Diagnostics collaborated with DIPAS DRDO to jointly develop the DIPAS-VDx Covid-19 IgG Antibody ELISA Test kit for the detection of Covid-19 IgG antibody in June 2020. The product received ICMR approval and a license to manufacture from the CDSCO. The kit has been commercialized successfully.

The company follows a B2B model in business, positioning itself as a development and manufacturing entity in the various segments of in-vitro diagnostics like Hematology, Clinical Chemistry and Rapid Card Tests, ELISA Kits and Flowcytometry reagents with a capacity to manufacture 1.5Mn Litres of IVD reagents annually. 

Recently, Vanguard Diagnostics has announced the formation of Diagon - Vanguard Diagnostics India (P) Limited, a joint venture between long-term partners – Diagon Ltd, Hungary and Vanguard Diagnostics (P) Ltd.


“We are engaged in the manufacturing of in-vitro diagnostics reagents covering Hematology, Clinical Chemistry, Immunology and Covid-19 solutions. In addition, we manufacture Rapid Card Tests for communicable tropical infections like Malaria, Dengue, Chikungunya, Typhoid and Leptospirosis. We position ourselves as being the first-choice partner, for all non-manufacturing companies based in India and the sub-continent. Our model aims at reducing the need for import and giving an impetus to the ‘Make in India’ initiative. Our endeavour is to incrementally improve healthcare in India via innovation and self-reliance” says Veena Kohli CEO and Founder of Vanguard Diagnostics.


At a glance



Vanguard Diagnostics has taken positive and measurable steps to introduce high quality and affordable diagnostics tools across relevant markets through their customized manufacturing & technical capabilities contributing to increasing level of self-reliance in the Indian IVD space.


•    The big differentiator of Brand Vanguard is its team. The organization was founded by a motivated group of professionals with unparalleled understanding, skills and expertise in the diagnostics sector, and a cumulative experience of over 100 years in the diagnostics industry. The founders have a complete chain of capabilities, ranging from R&D, Manufacturing, Quality, Marketing and Supply Chain to Business Leadership - Domestic & Global. 

•    Vanguard is also equipped with a formidable development team and high production capacity. They possess a state-of-the-art automated Hematology reagent plant, with an annual capacity of producing 1.5 million Litres of reagents per year.

•    The team has introduced the world’s most stable and reliable Hematology Controls in India. This will enable all sizes of Indian labs to produce results comparable in reliability with international labs.



To develop, manufacture and market diagnostic products that stand for Responsibility & Reliability. 


Vanguard Diagnostics’ vision is to make India increasingly self-reliant in the in vitro diagnostics domain.


To provide high quality, affordable diagnostics tools across relevant markets through our customized manufacturing and technical capabilities.


Achievements and Accolades of Vanguard Diagnostics and CEO/Owner Veena Kohli

•    FICCI Healthcare Excellence Award 2020 for ‘Excellence in Scaling-up of Manufacturing for COVID Demand’, September, 2020.

•    ‘Best Woman Entrepreneur Award’, Dun & Bradstreet - November, 2019.

•    CEO with HR Orientation Award, ZEE Business, 2019. 

•    100 Most Impactful Leaders in Healthcare Award, World Mental Health & Wellness Congress, 2019 & 2020.

•    Finalist, National Start-Up India Awards, 2021.  


Future milestones and events coming up.

Vanguard Diagnostics has announced the formation of Diagon - Vanguard Diagnostics India (P) Limited, a joint venture between long-term partners – Diagon Ltd, Hungary and Vanguard Diagnostics (P) Ltd.
“This venture will offer the world’s best range of Haemostasis / Coagulation reagents and instruments to cater to the needs of all types of diagnostics laboratories. We are delighted to launch, our Dia D-Dimer Quantitative Test - which can be used on several models of instruments including all Diagon Coagulation analysers. The future is truly exciting for us, and we are committed to fighting this global pandemic.” shares Veena Kohli.


Veena Kohli is the CEO and Founder of Vanguard Diagnostics and the Managing director of the newly formed JV, Diagon-Vanguard Diagnostics India.

As an accomplished and award-winning leader in Medical Diagnostics, Veena has led global businesses, set up companies and nurtured talent into senior management positions. With over 30 years of experience, she has led large teams across various functions ranging from R&D to the Global P&L.

Additionally, Veena also serves as President, Association of Diagnostics Manufacturers of India (ADMI); Convenor, IVD sub-group at the Bureau of Indian Standards (BIS); Member, Standing Forum of Medical Devices Associations, Department of Pharma,  Ministry of  Chemicals & Fertilizers; Member, Committee for planning the way forward for Covid-19 Medical Devices, Department of Pharma, Ministry of Chemicals & Fertilizers; Member, Committee for examining issues related to Medical Devices, Department of Pharma, Ministry of Chemicals & Fertilizers. Member, National Medical Devices Promotion Council, DPIIT, Ministry of Commerce and Industry; Member, Medical Devices Technical Advisory Group (MDTAG), CDSCO, Ministry of Health & Family Welfare; Mentor, Regional Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology; Technical Representative for IVD from India for the 22nd Asian Harmonization Working Party by CDSCO, Ministry of Health & Family Welfare, Government of India.

An alumnus of the All India Institute of Medical Sciences (AIIMS), New Delhi, Kohli has formerly worked in senior leadership roles at blue-chip organisations like Ranbaxy Laboratories Limited, Ranbaxy Fine Chemicals Limited, and Avantor Performance Materials – USA, where she served as the Global Head of the Diagnostics SBU before embarking upon her entrepreneurial journey with Vanguard Diagnostics.

Partners & Associate